iBio, Inc.
IBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001420720
No open-market purchases or sales by iBio, Inc. insiders were filed in the last 90 days; 55 institutions reported holding it in 13F filings for Q2 2026, worth $60.8M in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in iBio, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 32
- +3 vs. Q2 2025
- Shares held
- 3.57M
- +365.9K (+11.4%) vs. Q2 2025
- Total value
- $2.96M
- +$511.2K (+20.9%) vs. Q2 2025
- New holders
- 6
- 8 more added
- Sold out
- 3
- 6 more reduced
1 institution that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IBIO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 55 | $60.8M |
| Q1 2026 | 52 | $36.9M |
| Q4 2025 | 50 | $31.6M |
| Q3 2025 | 32 | $2.96M |
| Q2 2025 | 30 | $2.44M |
| Q1 2025 | 34 | $10.4M |
| Q4 2024 | 30 | $6.40M |
| Q3 2024 | 32 | $5.79M |
| Q2 2024 | 28 | $5.68M |
| Q1 2024 | 28 | $11.5M |
| Q4 2023 | 21 | $344.6K |
| Q3 2023 | 29 | $269.9K |
| Q2 2023 | 29 | $695.7K |
| Q1 2023 | 30 | $3.45M |
| Q4 2022 | 38 | $1.02M |
| Q3 2022 | 46 | $4.97M |
| Q2 2022 | 57 | $7.63M |
| Q1 2022 | 77 | $17.5M |
| Q4 2021 | 83 | $25.0M |
| Q3 2021 | 90 | $47.6M |
| Q2 2021 | 87 | $65.5M |
| Q1 2021 | 94 | $68.5M |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding iBio, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Lynx1 Capital Management LP | 1,055,897 | $874.1K | 0.18% | −482,676−31.4% | Reduced |
| Ikarian Capital, LLC | 617,327 | $511.0K | 0.12% | +17,414+2.9% | Added |
| Ameriprise Financial Inc | 482,300 | $399.2K | 0.00% | +482,300 | New |
| Opaleye Management Inc. | 375,000 | $310.4K | 0.04% | 00.0% | Unchanged |
| Vanguard Group Inc | 274,070 | $226.9K | 0.00% | +130,209+90.5% | Added |
| Boothbay Fund Management, LLC | 176,862 | $146.4K | 0.00% | +17,414+10.9% | Added |
| Geode Capital Management, LLC | 151,309 | $125.3K | 0.00% | +39,008+34.7% | Added |
| Citadel Advisors LLC | 131,958 | $109.2K | 0.00% | +131,958 | New |
| Two Sigma Securities, LLC | 45,079 | $37.3K | 0.01% | +16,517+57.8% | Added |
| Susquehanna International Group, LLP | 44,471 | $36.8K | 0.00% | +44,471 | New |
| BlackRock, Inc. | 42,727 | $35.4K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 41,900 | $35.0K | 0.00% | +1,719+4.3% | Added |
| HRT Financial LP | 34,157 | $28.0K | 0.00% | +34,157 | New |
| State Street Corp | 33,699 | $27.9K | 0.00% | 00.0% | Unchanged |
| ADAR1 Capital Management, LLC | 27,000 | $22.4K | 0.00% | −27,819−50.7% | Reduced |
| Northern Trust Corp | 23,044 | $19.1K | 0.00% | 00.0% | Unchanged |
| Balyasny Asset Management LLC | 10,400 | $8.61K | 0.00% | +10,400 | New |
| Tower Research Capital LLC (TRC) | 1,733 | $1.44K | 0.00% | −374−17.8% | Reduced |
| Advisor Group Holdings, Inc. | 704 | $575 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 145 | $120 | 0.00% | −12−7.6% | Reduced |
| SRS Capital Advisors, Inc. | 91 | $76 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 57 | $47 | 0.00% | +8+16.3% | Added |
| SBI Securities Co., Ltd. | 22 | $18 | 0.00% | −201−90.1% | Reduced |
| SOA Wealth Advisors, LLC. | 13 | $11 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 5 | $4 | 0.00% | 00.0% | Unchanged |
| City Holding Co | 4 | $3 | 0.00% | 00.0% | Unchanged |
| Activest Wealth Management | 4 | $3 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 4 | $3 | 0.00% | +3+300.0% | Added |
| JPMorgan Chase & Co | 2 | $2 | 0.00% | 00.0% | Unchanged |
| Sofos Investments, Inc. | 2 | $2 | 0.00% | +2 | New |
| UBS Group AG | 1 | $1 | 0.00% | −28,602−100.0% | Reduced |
| Steward Partners Investment Advisory, LLC | 1 | $1 | 0.00% | 00.0% | Unchanged |
| Dauntless Investment Group, LLC | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Atlantic Union Bankshares Corp | 0 | $0 | 0.00% | −14−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Financial Gravity Companies, Inc. | – | – | – | – | Not filed |